Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Zawartość zarchiwizowana w dniu 2024-04-16

ALKALI LEACHING FROM PHARMACEUTICAL GLASS CONTAINERS

Cel



Glass containers for injectable solutions must comply with specifications of the European Pharmacopoeia (also ISO 4802) which limit the release of alkaline constituents into pure water when applying a specific test. The test method consists of:
- applying a specified temperature cycle to containers, partially filled with pure water(in equilibrium with the atmosphere), in an autoclave
- subsequent determination of total alkalinity (titration) of the water or of specified elements (Na and possibly others).
The test method imposed by the European Pharmacopoeia is not ideal. The test is very sensitive to minor differences in the temperature cycle applied. It appears in fact that most cases of observed high leaching are caused by measurement errors and not by poor quality of the glass. Potential sources of error have been identified and largely eliminated in preliminary intercomparisons. A reference material will be certified to enable laboratories to check if the method is applied correctly.

Temat(-y)

Data not available

Zaproszenie do składania wniosków

Data not available

System finansowania

CSC - Cost-sharing contracts

Koordynator

Institut National du Verre
Wkład UE
Brak danych
Adres

Charleroi
Belgia

Zobacz na mapie

Koszt całkowity
Brak danych

Uczestnicy (12)